WHO statement on AstraZeneca COVID-19 vaccine safety signals – World Health Organization Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)   Commentary on Twitter (thread – click for more) At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue. Full statement […]

The post WHO Statement | The benefits of the AstraZeneca vaccine outweigh its risks – vaccinations should continue appeared first on Links Medicus.

COVID antibody treatments show promise for preventing severe disease – Nature  

The post COVID antibody treatments show promise for preventing severe disease appeared first on Links Medicus.

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19 Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19  

The post FDA: Why you should not use Ivermectin to treat or prevent COVID-19 appeared first on Links Medicus.

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients – JAMA  

The post Immunogenicity of a single dose of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients appeared first on Links Medicus.

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant – New England Journal of Medicine Commentaries: AstraZeneca vaccine doesn’t prevent B1351 COVID in early trial – CIDRAP AND Oxford/AstraZeneca Fails to Prevent Mild to Moderate Covid-19 From B.1.351 (“South Africa”) Variant – Brief19  

The post RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant appeared first on Links Medicus.

The Oxygen Cascade During Exercise in Health and Disease – Mayo Clinic Proceedings  

The post The oxygen cascade during exercise in health and disease appeared first on Links Medicus.

More Than Half of COVID-19 Patients Report Depressive Symptoms Months Later, Study Finds – Psychiatric News Alert Original study: Association of Acute Symptoms of COVID-19 and Symptoms of Depression in Adults – JAMA Network Open   Commentary on Twitter Survey study finds 52% of individuals with prior #COVID19 met criteria for moderate or greater symptoms […]

The post More than half of COVID-19 patients report depressive symptoms months later, study finds appeared first on Links Medicus.

What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1) – Annals of Internal Medicine  

The post ACP Practice Points: What is the antibody response and role in conferring natural immunity after SARS-CoV-2 infection? appeared first on Links Medicus.

Antibody Response After SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review – Annals of Internal Medicine  

The post Antibody response after SARS-CoV-2 infection and implications for immunity: A rapid living review appeared first on Links Medicus.

B.1.1.7 variant linked to 55% higher mortality compared to other strains of SARS-CoV-2 – London School of Hygiene & Tropical Medicine Original study: Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 – Nature Related: Death rate 64% higher with B117 COVID variant, study finds (study and commentary)   Commentary on Twitter (thread – Click […]

The post B.1.1.7 variant linked to 55% higher mortality compared to other strains of SARS-CoV-2 appeared first on Links Medicus.